The next-generation mass spectrometer market size has grown rapidly in recent years. It will grow from $3.6 billion in 2025 to $3.96 billion in 2026 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to limited sensitivity and resolution of early mass spectrometers, reliance on conventional ion trap and quadrupole systems, growing pharmaceutical and biotech research, increasing demand for accurate molecular analysis, high operational complexity and maintenance costs.
The next-generation mass spectrometer market size is expected to see strong growth in the next few years. It will grow to $5.75 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to development of next-generation ft-ms and orbitrap systems, integration of ai-based data interpretation, expansion of clinical diagnostics and forensic applications, rising environmental monitoring and food safety testing, demand for high-throughput and automated mass spectrometry systems. Major trends in the forecast period include rising demand for high-resolution mass spectrometry, integration of real-time data processing and analytics, expansion of proteomics and metabolomics research, increased adoption in environmental and food testing applications, focus on miniaturization and enhanced sensitivity of instruments.
The increasing focus on personalized medicine is expected to drive the growth of the next-generation mass spectrometer market in the coming years. Personalized medicine is a healthcare approach that customizes treatment and medical decisions based on an individual’s unique genetic, environmental, and lifestyle factors to achieve more effective outcomes. The rising emphasis on personalized medicine is driven by the need for tailored therapies that enhance patient outcomes, minimize side effects, and optimize healthcare efficiency according to individual genetic and lifestyle profiles. Next-generation mass spectrometers support personalized medicine by delivering highly precise and comprehensive molecular analyses, enabling the identification of patient-specific biomarkers, monitoring of therapeutic responses, and guidance of individualized treatment plans for improved outcomes. For example, in February 2024, the Personalized Medicine Coalition, a U.S.-based non-profit organization, reported that in 2023, the U.S. Food and Drug Administration (FDA) approved 16 new personalized medicines for rare disease patients, up from six in 2022. Consequently, the growing emphasis on personalized medicine is fueling the growth of the next-generation mass spectrometer market.
Major companies in the next-generation mass spectrometer market are focusing on developing highly efficient instruments that allow researchers to analyze complex biological samples with unprecedented speed and precision. These innovations aim to advance biomarker discovery, enable early disease detection, and accelerate the development of personalized therapies. For example, in June 2023, Thermo Fisher Scientific Inc., a U.S.-based clinical research company, launched the Orbitrap Astral mass spectrometer, representing one of the most significant advancements in mass spectrometry in the past 15 years. This next-generation instrument allows detection of previously inaccessible low-abundance proteins by combining ultra-fast scan speeds, exceptional sensitivity, and deep proteome coverage. It also features enhanced ion transmission efficiency, improved dynamic range, and up to four times higher throughput, facilitating faster biomarker discovery, precise protein quantification, and the development of targeted therapies across a wide range of diseases.
In July 2024, Thermo Fisher Scientific acquired Olink Holdings AB for $3.1 billion. This acquisition integrates Olink’s next-generation proteomics solutions into Thermo Fisher’s mass spectrometry portfolio, enhancing capabilities in protein analysis, accelerating scientific discovery, and supporting precision medicine initiatives. Olink Holdings AB, based in Sweden, specializes in advanced proteomics solutions for next-generation mass spectrometers.
Major companies operating in the next-generation mass spectrometer market are Hitachi Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., Shimadzu Corporation, Waters Corporation, Bruker Corporation, HORIBA Ltd., JEOL Ltd., Rigaku Corporation, LECO Corporation, Hiden Analytical Ltd., Scion Instruments Ltd., MOBILion Systems Inc., Jiangsu Skyray Instrument Co. Ltd., Advion Inc., Postnova Analytics GmbH, Kore Technology Ltd., Variolytics GmbH, Spectroswiss, Excellims Corporation, 908 Devices Inc.
North America was the largest region in the next-generation mass spectrometer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next-generation mass spectrometer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the next-generation mass spectrometer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the next-generation mass spectrometer market by increasing costs of imported precision components, ion optics, and high-resolution sensors. Segments such as ft-ms and linear ion trap mass spectrometers are most impacted, with Asia-Pacific regions like China and India facing higher import duties. This has led to increased instrument pricing and delays in delivery. On the positive side, tariffs are encouraging local manufacturing, investment in domestic R&D, and development of cost-optimized alternatives.
The next-generation mass spectrometer market research report is one of a series of new reports that provides next-generation mass spectrometer market statistics, including next-generation mass spectrometer industry global market size, regional shares, competitors with a next-generation mass spectrometer market share, detailed next-generation mass spectrometer market segments, market trends and opportunities, and any further data you may need to thrive in the next-generation mass spectrometer industry. This next-generation mass spectrometer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Next-generation mass spectrometers are advanced analytical instruments engineered to deliver ultra-high sensitivity, resolution, and speed for detecting and quantifying molecules across diverse applications, including proteomics, metabolomics, drug discovery, and environmental analysis. These instruments often incorporate cutting-edge technologies such as artificial intelligence, novel ion optics, and real-time data processing to enhance performance, minimize sample requirements, and provide more precise and comprehensive molecular insights.
The primary types of next-generation mass spectrometers include Fourier transform mass spectrometry, linear ion trap mass spectrometry, and others. Fourier transform mass spectrometry uses a mathematical approach to convert a time-domain signal into its frequency-domain representation, revealing how the signal’s energy is distributed across different frequencies. Key applications span pharmaceuticals, biotechnology, clinical diagnostics, environmental analysis, food and beverage testing, forensic science, and more. End users include research laboratories, academic institutions, pharmaceutical companies, biotechnology firms, clinical laboratories, and government agencies.
The next-generation mass spectrometer consists of sales of electrospray ionization, atmospheric pressure chemical ionization, trapped ion mobility spectrometry, faraday cups, and photodiode arrays. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The next-generation mass spectrometer market size is expected to see strong growth in the next few years. It will grow to $5.75 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to development of next-generation ft-ms and orbitrap systems, integration of ai-based data interpretation, expansion of clinical diagnostics and forensic applications, rising environmental monitoring and food safety testing, demand for high-throughput and automated mass spectrometry systems. Major trends in the forecast period include rising demand for high-resolution mass spectrometry, integration of real-time data processing and analytics, expansion of proteomics and metabolomics research, increased adoption in environmental and food testing applications, focus on miniaturization and enhanced sensitivity of instruments.
The increasing focus on personalized medicine is expected to drive the growth of the next-generation mass spectrometer market in the coming years. Personalized medicine is a healthcare approach that customizes treatment and medical decisions based on an individual’s unique genetic, environmental, and lifestyle factors to achieve more effective outcomes. The rising emphasis on personalized medicine is driven by the need for tailored therapies that enhance patient outcomes, minimize side effects, and optimize healthcare efficiency according to individual genetic and lifestyle profiles. Next-generation mass spectrometers support personalized medicine by delivering highly precise and comprehensive molecular analyses, enabling the identification of patient-specific biomarkers, monitoring of therapeutic responses, and guidance of individualized treatment plans for improved outcomes. For example, in February 2024, the Personalized Medicine Coalition, a U.S.-based non-profit organization, reported that in 2023, the U.S. Food and Drug Administration (FDA) approved 16 new personalized medicines for rare disease patients, up from six in 2022. Consequently, the growing emphasis on personalized medicine is fueling the growth of the next-generation mass spectrometer market.
Major companies in the next-generation mass spectrometer market are focusing on developing highly efficient instruments that allow researchers to analyze complex biological samples with unprecedented speed and precision. These innovations aim to advance biomarker discovery, enable early disease detection, and accelerate the development of personalized therapies. For example, in June 2023, Thermo Fisher Scientific Inc., a U.S.-based clinical research company, launched the Orbitrap Astral mass spectrometer, representing one of the most significant advancements in mass spectrometry in the past 15 years. This next-generation instrument allows detection of previously inaccessible low-abundance proteins by combining ultra-fast scan speeds, exceptional sensitivity, and deep proteome coverage. It also features enhanced ion transmission efficiency, improved dynamic range, and up to four times higher throughput, facilitating faster biomarker discovery, precise protein quantification, and the development of targeted therapies across a wide range of diseases.
In July 2024, Thermo Fisher Scientific acquired Olink Holdings AB for $3.1 billion. This acquisition integrates Olink’s next-generation proteomics solutions into Thermo Fisher’s mass spectrometry portfolio, enhancing capabilities in protein analysis, accelerating scientific discovery, and supporting precision medicine initiatives. Olink Holdings AB, based in Sweden, specializes in advanced proteomics solutions for next-generation mass spectrometers.
Major companies operating in the next-generation mass spectrometer market are Hitachi Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., Shimadzu Corporation, Waters Corporation, Bruker Corporation, HORIBA Ltd., JEOL Ltd., Rigaku Corporation, LECO Corporation, Hiden Analytical Ltd., Scion Instruments Ltd., MOBILion Systems Inc., Jiangsu Skyray Instrument Co. Ltd., Advion Inc., Postnova Analytics GmbH, Kore Technology Ltd., Variolytics GmbH, Spectroswiss, Excellims Corporation, 908 Devices Inc.
North America was the largest region in the next-generation mass spectrometer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next-generation mass spectrometer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the next-generation mass spectrometer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the next-generation mass spectrometer market by increasing costs of imported precision components, ion optics, and high-resolution sensors. Segments such as ft-ms and linear ion trap mass spectrometers are most impacted, with Asia-Pacific regions like China and India facing higher import duties. This has led to increased instrument pricing and delays in delivery. On the positive side, tariffs are encouraging local manufacturing, investment in domestic R&D, and development of cost-optimized alternatives.
The next-generation mass spectrometer market research report is one of a series of new reports that provides next-generation mass spectrometer market statistics, including next-generation mass spectrometer industry global market size, regional shares, competitors with a next-generation mass spectrometer market share, detailed next-generation mass spectrometer market segments, market trends and opportunities, and any further data you may need to thrive in the next-generation mass spectrometer industry. This next-generation mass spectrometer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Next-generation mass spectrometers are advanced analytical instruments engineered to deliver ultra-high sensitivity, resolution, and speed for detecting and quantifying molecules across diverse applications, including proteomics, metabolomics, drug discovery, and environmental analysis. These instruments often incorporate cutting-edge technologies such as artificial intelligence, novel ion optics, and real-time data processing to enhance performance, minimize sample requirements, and provide more precise and comprehensive molecular insights.
The primary types of next-generation mass spectrometers include Fourier transform mass spectrometry, linear ion trap mass spectrometry, and others. Fourier transform mass spectrometry uses a mathematical approach to convert a time-domain signal into its frequency-domain representation, revealing how the signal’s energy is distributed across different frequencies. Key applications span pharmaceuticals, biotechnology, clinical diagnostics, environmental analysis, food and beverage testing, forensic science, and more. End users include research laboratories, academic institutions, pharmaceutical companies, biotechnology firms, clinical laboratories, and government agencies.
The next-generation mass spectrometer consists of sales of electrospray ionization, atmospheric pressure chemical ionization, trapped ion mobility spectrometry, faraday cups, and photodiode arrays. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Next-Generation Mass Spectrometer Market Characteristics
3. Next-Generation Mass Spectrometer Market Supply Chain Analysis
4. Global Next-Generation Mass Spectrometer Market Trends and Strategies
5. Next-Generation Mass Spectrometer Market Analysis of End Use Industries
7. Global Next-Generation Mass Spectrometer Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Next-Generation Mass Spectrometer Total Addressable Market (TAM) Analysis for the Market
9. Next-Generation Mass Spectrometer Market Segmentation
10. Next-Generation Mass Spectrometer Market Regional and Country Analysis
11. Asia-Pacific Next-Generation Mass Spectrometer Market
12. China Next-Generation Mass Spectrometer Market
13. India Next-Generation Mass Spectrometer Market
14. Japan Next-Generation Mass Spectrometer Market
15. Australia Next-Generation Mass Spectrometer Market
16. Indonesia Next-Generation Mass Spectrometer Market
17. South Korea Next-Generation Mass Spectrometer Market
18. Taiwan Next-Generation Mass Spectrometer Market
19. South East Asia Next-Generation Mass Spectrometer Market
20. Western Europe Next-Generation Mass Spectrometer Market
21. UK Next-Generation Mass Spectrometer Market
22. Germany Next-Generation Mass Spectrometer Market
23. France Next-Generation Mass Spectrometer Market
24. Italy Next-Generation Mass Spectrometer Market
25. Spain Next-Generation Mass Spectrometer Market
26. Eastern Europe Next-Generation Mass Spectrometer Market
27. Russia Next-Generation Mass Spectrometer Market
28. North America Next-Generation Mass Spectrometer Market
29. USA Next-Generation Mass Spectrometer Market
30. Canada Next-Generation Mass Spectrometer Market
31. South America Next-Generation Mass Spectrometer Market
32. Brazil Next-Generation Mass Spectrometer Market
33. Middle East Next-Generation Mass Spectrometer Market
34. Africa Next-Generation Mass Spectrometer Market
36. Next-Generation Mass Spectrometer Market Competitive Landscape and Company Profiles
37. Next-Generation Mass Spectrometer Market Other Major and Innovative Companies
40. Next-Generation Mass Spectrometer Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Next-Generation Mass Spectrometer Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses next-generation mass spectrometer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for next-generation mass spectrometer? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The next-generation mass spectrometer market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Fourier Transform; Linear Ion Trap Mass Spectrometry; Other Types2) By Application: Pharmaceuticals; Biotechnology; Clinical Diagnostics; Environmental Analysis; Food And Beverage Testing; Forensic Science; Other Applications
3) By End User: Research Laboratories; Academic Institutions; Pharmaceutical Companies; Biotechnology Firms; Clinical Laboratories; Government Agencies
Subsegments:
1) By Fourier Transform: Fourier Transform Ion Cyclotron Resonance (FT-ICR); Fourier Transform Orbitrap Mass Spectrometry; Hybrid FT-MS Systems; High-Resolution Accurate Mass (HRAM) FT-MS2) By Linear Ion Trap Mass Spectrometry: Quadrupole Ion Trap; Three-Dimensional Linear Ion Trap; Dual-Pressure Linear Ion Trap; Linear Ion Trap-Time Of Flight (LIT-TOF) Hybrid
3) By Other Types: Time-Of-Flight Mass Spectrometry (TOF-MS); Quadrupole Mass Spectrometry; Orbitrap Mass Spectrometry (Non-FT Applications); Magnetic Sector Mass Spectrometry; Ion Mobility Mass Spectrometry; Hybrid Mass Spectrometers
Companies Mentioned: Hitachi Ltd.; Thermo Fisher Scientific Inc.; Danaher Corporation; Agilent Technologies Inc.; PerkinElmer Inc.; Shimadzu Corporation; Waters Corporation; Bruker Corporation; HORIBA Ltd.; JEOL Ltd.; Rigaku Corporation; LECO Corporation; Hiden Analytical Ltd.; Scion Instruments Ltd.; MOBILion Systems Inc.; Jiangsu Skyray Instrument Co. Ltd.; Advion Inc.; Postnova Analytics GmbH; Kore Technology Ltd.; Variolytics GmbH; Spectroswiss; Excellims Corporation; 908 Devices Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Next-Generation Mass Spectrometer market report include:- Hitachi Ltd.
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Agilent Technologies Inc.
- PerkinElmer Inc.
- Shimadzu Corporation
- Waters Corporation
- Bruker Corporation
- HORIBA Ltd.
- JEOL Ltd.
- Rigaku Corporation
- LECO Corporation
- Hiden Analytical Ltd.
- Scion Instruments Ltd.
- MOBILion Systems Inc.
- Jiangsu Skyray Instrument Co. Ltd.
- Advion Inc.
- Postnova Analytics GmbH
- Kore Technology Ltd.
- Variolytics GmbH
- Spectroswiss
- Excellims Corporation
- 908 Devices Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.96 Billion |
| Forecasted Market Value ( USD | $ 5.75 Billion |
| Compound Annual Growth Rate | 9.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
